Business Context and Reporting Period
Company: MicroVision, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2026 (Event Date)
Closing Date: August 17, 2026
Context: The Company entered into a securities purchase agreement to conduct a confidentially marketed public offering of common stock and warrants.
Key Financial Metrics
- Securities Issued: 6,800,000 shares of Common Stock and accompanying warrants to purchase 6,800,000 shares.
- Offering Price: $2.50 per Share and accompanying Warrant (combined).
- Warrant Terms: Exercise price of $2.50 per share; exercisable immediately for a period of five years.
- Gross Proceeds: Approximately $17.0 million (6,800,000 units x $2.50).
- Net Proceeds: Approximately $15.6 million after deducting placement fees and estimated offering expenses.
- Placement Agent Fees: 6.5% cash fee of aggregate gross proceeds plus $115,000 in reimbursed expenses.
- Use of Proceeds: General corporate purposes, including working capital and capital expenditures.
- Debt/Liquidity: The filing does not provide specific current debt balances or liquidity ratios, but notes a restriction on repaying senior secured convertible notes maturing March 1, 2028.
Material Changes
This filing represents a material capital raise event rather than a periodic financial performance report. The primary material change is the increase in outstanding share count and the creation of warrant obligations. The filing does not provide comparative financial data (revenue, profit, margins) against prior periods.
Guidance, Outlook, and Restrictions
- Lock-Up/Restrictions: For 45 days following the closing (August 17, 2026), the Company agreed not to:
- Issue or announce the issuance of common stock or convertible securities (with limited exceptions).
- Issue securities subject to price resets based on trading prices.
- Make additional repayments on outstanding senior secured convertible notes maturing March 1, 2028.
- Management Commentary: The Company intends to use proceeds for general corporate purposes. No specific operational guidance or revenue outlook was provided in this text.
- Risks/Contingencies: The Purchase Agreement and Placement Agency Agreement contain customary representations, warranties, and indemnification obligations. The filing notes that the description of these agreements is qualified by reference to the exhibits.
Investor Verification Checklist
- Verify the final number of shares issued and the exact closing date (August 17, 2026) in subsequent filings.
- Review the full text of the Placement Agency Agreement (Exhibit 1.1) and Securities Purchase Agreement (Exhibit 10.1) for specific covenants and conditions.
- Confirm the impact of the 6.5% placement fee and $115,000 expense reimbursement on the final net cash position.
- Monitor the 45-day restriction period regarding the repayment of senior secured convertible notes maturing in 2028.
- Check the Form S-3 (File No. 333-297430) for the full prospectus details regarding the Offering.